Evolent Health (EVH) Expected to Announce Earnings on Thursday

Evolent Health (NYSE:EVH) is projected to release its earnings data after the market closes on Thursday, February 20th. Analysts expect Evolent Health to post earnings of $0.38 per share and revenue of $650.92 million for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Evolent Health Stock Up 0.7 %

Evolent Health stock opened at $10.09 on Wednesday. Evolent Health has a fifty-two week low of $9.45 and a fifty-two week high of $35.00. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a 50 day moving average price of $10.82 and a 200 day moving average price of $19.04. The company has a market capitalization of $1.18 billion, a PE ratio of -11.09 and a beta of 1.45.

Analyst Upgrades and Downgrades

Several research firms have commented on EVH. JMP Securities restated a “market outperform” rating and issued a $12.00 price target on shares of Evolent Health in a research note on Friday, February 14th. Truist Financial dropped their price target on shares of Evolent Health from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Wednesday, January 22nd. UBS Group dropped their price target on shares of Evolent Health from $27.00 to $14.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. BTIG Research dropped their price target on shares of Evolent Health from $36.00 to $29.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Finally, Oppenheimer dropped their price target on shares of Evolent Health from $28.00 to $18.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $17.92.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.